Back to Journals » Biologics: Targets and Therapy » Volume 13

Efficacy of adalimumab as second-line therapy in a pediatric cohort of Crohn’s disease patients who failed infliximab therapy: the Italian Society of Pediatric Gastroenterology, Hepatology, and Nutrition experience

Total article views   HTML views PDF downloads Totals
8,466 Dovepress* 7,657+ 1,608 9,265
PubMed Central* 809 317 1,126
Totals 8,466 1,925 10,391
*Since 3 January 2019
Total mentioned Facebook Delicious Reddit Twitter Others
9 0 0 0 1 8

View citations on PubMed Central and Google Scholar